Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma

Ipilimumab has revolutionized malignant melanoma therapy, but a better understanding of the mechanisms behind treatment response and adverse effects is needed. In this work, the immune system of ipilimumab treated patients was monitored to investigate potential mechanisms of action that may correlat...

Descripción completa

Detalles Bibliográficos
Autores principales: de Coaña, Yago Pico, Wolodarski, Maria, Poschke, Isabel, Yoshimoto, Yuya, Yang, Yuan, Nyström, Maria, Edbäck, Ulrika, Brage, Suzanne Eghyazi, Lundqvist, Andreas, Masucci, Giuseppe V., Hansson, Johan, Kiessling, Rolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400604/
https://www.ncbi.nlm.nih.gov/pubmed/28423487
http://dx.doi.org/10.18632/oncotarget.15368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400604/
https://www.ncbi.nlm.nih.gov/pubmed/28423487
http://dx.doi.org/10.18632/oncotarget.15368

Ejemplares similares